Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey

被引：0
|
作者：
Hiroki Murayama
Kota Imai
Masato Odawara
机构：
[1] Novartis Pharma K.K,Medical Division
[2] Tokyo Medical University,Department of Diabetes, Endocrinology, Metabolism, and Rheumatology
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Dipeptidyl peptidase-4 inhibitor; Diabetes nonspecialist; Diabetes specialist; Drug-naive; Japan; First line; Metformin; Online survey; Oral antidiabetes drugs; Treatment choices; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1185 / 1199
页数：14
相关论文
共 50 条
  • [41] Real-world safety of dapagliflozin plus metformin in patients of type 2 diabetes mellitus in China: Post-hoc analysis of the DONATE study
    Guo, Lixin
    Wang, Jing
    Li, Li
    Yuan, Lin
    Chen, Sheng
    Wang, Hui
    Li, Tonghuan
    Qi, Lin
    Yang, Hong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 219
  • [42] Improved Clinical Outcomes with Dulaglutide as Add-on Medication to Oral Antidiabetic Drugs with or Without Insulin in Overweight Indian Patients with Type 2 Diabetes Mellitus: Retrospective Study in a Real-World Setting
    Ghosh, Aneesh
    Nair, Rakhee
    CURRENT DIABETES REVIEWS, 2020, 16 (05) : 490 - 496
  • [43] Real-world HbA1c changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes
    Frazer, Monica
    Swift, Caroline
    Sargent, Andrew
    Leszko, Michael
    Buysman, Erin
    Gronroos, Noelle N.
    Alvarez, Sara
    Dunn, Tyler J.
    Noone, Josh
    Gamble, Cory L.
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 23 (01) : 783 - 788
  • [44] Correlation between long-term use of metformin and incidence of NAFLD among patients with type 2 diabetes mellitus: A real-world cohort study
    Huang, Kuang-Hua
    Lee, Chiu-Hsiang
    Cheng, Yih-Dih
    Gau, Shuo-Yan
    Tsai, Tung-Han
    Chung, Ning-Jen
    Lee, Chien-Ying
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [45] Sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes in North India: A 12-month prospective study in real-world setting
    Ghosh, Amerta
    Gupta, Ritesh
    Singh, Padam
    Dutta, Abhinav
    Misra, Anoop
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2018, 72 (09)
  • [46] Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance
    Inagaki, Nobuya
    Nangaku, Masaomi
    Sakata, Yasushi
    Sasaki, Kazuyo
    Mori-Anai, Kazumi
    Iwasaki, Tomohisa
    Hamada, Koume
    ADVANCES IN THERAPY, 2022, 39 (01) : 674 - 691
  • [47] Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance
    Nobuya Inagaki
    Masaomi Nangaku
    Yasushi Sakata
    Kazuyo Sasaki
    Kazumi Mori-Anai
    Tomohisa Iwasaki
    Koume Hamada
    Advances in Therapy, 2022, 39 : 674 - 691
  • [48] Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
    Tajima, Atsushi
    Tobe, Keisuke
    Eiki, Jun-ichi
    Origasa, Hideki
    Watada, Hirotaka
    Shimomura, Iichiro
    Tokita, Shigeru
    Kadowaki, Takashi
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (06)
  • [49] Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naive patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial
    Roden, Michael
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans J.
    Broedl, Uli C.
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [50] Once-weekly semaglutide use in patients with type 2 diabetes: Real-world data from the SURE Italy observational study
    Napoli, Raffaele
    Berra, Cesare
    Catarig, Andrei-Mircea
    Di Loreto, Chiara
    Donatiello, Emily
    Berentzen, Tina Landsvig
    Pitocco, Dario
    Giorgino, Francesco
    DIABETES OBESITY & METABOLISM, 2023, 25 (06) : 1658 - 1667
12345